Skip to main content
More Search Options
A member of our team will call you back within one business day.
Convened IRB meetings are always held on the third (3rd) Friday of the month. The agenda for materials that require review by the convened IRB closes once eight (8) agenda items have been received or 12 working days prior to the convened meeting date – whichever occurs first. Only complete submission materials will be placed on the agenda so it is important to double check materials before delivering them to the ORTD office for consideration.
Materials that do not require review by the convened IRB do not have a deadline for submission and are assigned for review as received.
Protection of Human Subjects
Conflict of Interest
To access this training go to citiprogram.org. Use the username and password that you already have to log on. Once logged on, select the link for the Good Clinical Practice training information and follow the instructions on the site to gain access to the modules.
To access this training go to citiprogram.org. Use the username and password that you already have to log on. Once logged on, select the link for the Responsible Conduct in Research training information and follow the instructions on the site to gain access to the modules.
To access this training go to citiprogram.org. Use the username and password that you already have to log on. Once logged on, select the link for the Health Information Privacy and Security training information and follow the instructions on the site to gain access to the modules.
Research Information sessions are held monthly on the Tuesday before the IRB meeting from 2-3 in the Korman Builiding, conference room B-16. The meetings are open to any Einstein employee and cover a variety of research topics.
There is a Biostatistics website, which is an educational resource for all EHN staff interested in medical research.
There is an introductory biostatistics course offered annually that is available for free to any Einstein employee. For course details, refer to the website above or contact Dr. Leonard Braitman at email@example.com. No prior knowledge of statistics is required to attend this course.
Continuing Review - Open to Enrollment
Continuing Review - Long Term Follow Up
Modification to Approved Research
Response to IRB Review
Reportable New Information
IRB Submission Process Specific to AES Funding
Contact Information (form 201)
Application (form 211)
Addendum to the Application (form 211A)
Protocol Summary (form 204)
Continuing Review/Study closure (form 212)
Addendum to Continuing Review (form 212A)
Modification to Approved Research (form 213)
Response to IRB review (form 214)
Reportable New Information (form 219)
Emergency Use Report form (form 220)
Initial Submission Funding and NCT Information
Template Consent Form
Template Assent Form
Template Audio, Video, Photo Permission Form
Template Tissue Sample Consent Form
Contact the Director of the ORTD, Mary Klein at 215-456-7215 or via email at firstname.lastname@example.org.
Department of Health and Human Services (DHHS)
Office of Human Research ProtectionFrequently referenced:
Food and Drug Administration FDA Information sheet guidance for IRB’s, Clinical Investigators, and Sponsors
International Code of Harminisation – Good Clinical Practice (ICH GCP) Guidance for Industry – E6 GCP
International Committee of Medical Journal Editors (ICMJE)
National Institutes of Health
Health Information Portability and Accountability Act and Research
Association for the Accreditation of Human Research Protections Programs (AAHRPP)
Public Responsibility in Medicine and Research (PRIM&R)